Tamoxifen and Estrogen Effects on TGF-β Formation: Role of Thrombospondin-1, αvβ3, and Integrin-Associated Protein
- 1 June 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 284 (1) , 11-14
- https://doi.org/10.1006/bbrc.2001.4922
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Activation of Platelet-transforming Growth Factor β-1 in the Absence of Thrombospondin-1Published by Elsevier ,2000
- The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-βJournal of Biological Chemistry, 1999
- A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1Cell, 1999
- Thrombospondin-1 Is a Major Activator of TGF-β1 In VivoPublished by Elsevier ,1998
- Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human SalivaThe Journal of Experimental Medicine, 1998
- Latent transforming growth factor-β: Structural features and mechanisms of activationKidney International, 1997
- Regulation of differentiation by TFG-βCurrent Opinion in Genetics & Development, 1996
- Regulation of Transforming Growth Factor-β Activation by Discrete Sequences of Thrombospondin 1Journal of Biological Chemistry, 1995
- The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.Genes & Development, 1994
- Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancerBritish Journal of Cancer, 1991